Abstract:Administration of cisplatin, a common chemotherapeutic drug, has an inevitable side effect of sensorineural hearing loss. The main etiologies are stria vascularis injury, spiral ganglion degeneration, and hair cell death. Over several decades, the research scope of cisplatin-induced ototoxicity has expanded with the discovery of the molecular mechanism mediating inner ear cell death, highlighting the roles of reactive oxygen species and transport channels for cisplatin uptake into inner ear cells. Upon entering hair cells, cisplatin disrupts organelle metabolism, induces oxidative stress, and targets DNA to cause intracellular damage. Recent studies have also reported the role of inflammation in cisplatin-induced ototoxicity. In this article, we preform a narrative review of the latest reported molecular mechanisms of cisplatin-induced ototoxicity, from extracellular to intracellular. We build up a signaling network starting with cisplatin entering into the inner ear through the blood labyrinth barrier, disrupting cochlear endolymph homeostasis, and activating inflammatory responses of the outer hair cells. After entering the hair cells, cisplatin causes hair cell death via DNA damage, redox system imbalance, and mitochondrial and endoplasmic reticulum dysfunction, culminating in programmed cell death including apoptosis, necroptosis, autophagic death, pyroptosis, and ferroptosis. Based on the mentioned mechanisms, prominent therapeutic targets, such as channel-blocking drugs of cisplatin transporter, construction of cisplatin structural analogues, anti-inflammatory drugs, antioxidants, cell death inhibitors, and others, were collated. Considering the recent research efforts, we have analyzed the feasibility of the aforementioned therapeutic strategies and proposed our otoprotective approaches to overcome cisplatin-induced ototoxicity.

Mechanisms and otoprotective strategies of programmed cell death on aminoglycoside-induced ototoxicity

Theophylline Alleviates Gentamicin-Induced Cytotoxicity to Sensory Hair Cells by Maintaining HDAC2 Expression

Mitochondrial DNA mutations associated with aminoglycoside induced ototoxicity

A Biochemical Basis for the Inherited Susceptibility to Aminoglycoside Ototoxicity

Mitochondrial DNA Mutations Associated with Aminoglycoside Ototoxicity

Interaction of Aminoglycosides with Human Mitochondrial 12S Rrna Carrying the Deafness-Associated Mutation

Protection of Hair Cells from Ototoxic Drug-Induced Hearing Loss.

Cisplatin-induced ototoxicity: From signaling network to therapeutic targets

Hair Cell Protection from Ototoxic Drugs

Apoptosis, autophagy, ferroptosis, and pyroptosis in cisplatin-induced ototoxicity and protective agents

Mechanisms of hair cell death and protection

Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies

Programmed cell death pathways in hearing loss: A review of apoptosis, autophagy and programmed necrosis

Current Strategies to Combat Cisplatin-Induced Ototoxicity

Aminoglycoside Ototoxicity: Prevention in Sight?

Cisplatin ototoxicity mechanism and antagonistic intervention strategy: a scope review

Mechanisms of cisplatin ototoxicity and progress in otoprotection

The design and screening of drugs to prevent acquired sensorineural hearing loss

Mechanisms of Cisplatin-Induced Ototoxicity and Prevention

Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection

Functional and morphological analysis of different aminoglycoside treatment regimens inducing hearing loss in mice